Lonza EasyDiff supplements for bone marrow CD34+
Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.
Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.
There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.
The supplements are suitable for both drug discovery and toxicology research.
Phone: 03 9550 0883
AdipoGen Life Sciences tubulin products for neurodegeneration research
AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...
SYnAbs monoclonal antibodies
SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...
Merck VirusExpress Lentiviral Production Platform
The platform helps to overcome lentiviral production challenges and can reduce process...
Learn More
I am interested in Lonza EasyDiff supplements for bone marrow CD34+ .
Complete the form and a supplier representative will be in touch.
